Mychal James Bradley Gibbens

Array ( [id] => 14963071 [patent_doc_number] => 20190309013 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-10 [patent_title] => LINKER MOLECULE AND USE THEREOF IN METHODS FOR PURIFYING PEPTIDES [patent_app_type] => utility [patent_app_number] => 16/073794 [patent_app_country] => US [patent_app_date] => 2017-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14435 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16073794 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13970493 [patent_doc_number] => 10214589 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-02-26 [patent_title] => Site-specific antibody-drug conjugation through glycoengineering [patent_app_type] => utility [patent_app_number] => 15/417648 [patent_app_country] => US [patent_app_date] => 2017-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 42 [patent_figures_cnt] => 36 [patent_no_of_words] => 26906 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15417648 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11907088 [patent_doc_number] => 09775885 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-10-03 [patent_title] => 'TMD1 protein for treating bone loss diseases' [patent_app_type] => utility [patent_app_number] => 15/415806 [patent_app_country] => US [patent_app_date] => 2017-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 3000 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15415806 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15571535 [patent_doc_number] => 10576126 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-03-03 [patent_title] => Antitumor agent [patent_app_type] => utility [patent_app_number] => 16/071610 [patent_app_country] => US [patent_app_date] => 2017-01-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 26 [patent_no_of_words] => 4497 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16071610 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11948265 [patent_doc_number] => 20170252416 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-09-07 [patent_title] => 'TREATMENT OF DISEASE USING INTER-ALPHA INHIBITOR PROTEINS' [patent_app_type] => utility [patent_app_number] => 15/407805 [patent_app_country] => US [patent_app_date] => 2017-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 30624 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15407805 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 12049854 [patent_doc_number] => 20170326197 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-11-16 [patent_title] => 'METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING OPHTHALMIC CONDITIONS' [patent_app_type] => utility [patent_app_number] => 15/401527 [patent_app_country] => US [patent_app_date] => 2017-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 47 [patent_figures_cnt] => 47 [patent_no_of_words] => 22268 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15401527 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13774775 [patent_doc_number] => 20190000926 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-03 [patent_title] => CONTROLLED-RELEASE CNP AGONISTS WITH LOW NPR-C BINDING [patent_app_type] => utility [patent_app_number] => 16/066980 [patent_app_country] => US [patent_app_date] => 2017-01-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 55065 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -15 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16066980 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16405500 [patent_doc_number] => 10814038 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-10-27 [patent_title] => Combination compositions [patent_app_type] => utility [patent_app_number] => 16/064180 [patent_app_country] => US [patent_app_date] => 2016-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 26 [patent_no_of_words] => 13440 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16064180 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16948112 [patent_doc_number] => 20210206803 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-07-08 [patent_title] => THERAPEUTIC COMPOSITIONS INCLUDING PEPTIDES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/067514 [patent_app_country] => US [patent_app_date] => 2016-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11893 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -4 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16067514 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14929903 [patent_doc_number] => 20190300589 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-03 [patent_title] => POLYPEPTIDES FOR INHIBITING COMPLEMENT ACTIVATION [patent_app_type] => utility [patent_app_number] => 16/065272 [patent_app_country] => US [patent_app_date] => 2016-12-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9712 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -22 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16065272 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13774747 [patent_doc_number] => 20190000912 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-01-03 [patent_title] => COLLAGEN 7 COMPOSITIONS AND METHODS OF USING THE SAME [patent_app_type] => utility [patent_app_number] => 16/065512 [patent_app_country] => US [patent_app_date] => 2016-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4999 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -12 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16065512 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13618509 [patent_doc_number] => 20180360806 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-20 [patent_title] => THERAPEUTICS FOR PRETERM LABOR MANAGEMENT [patent_app_type] => utility [patent_app_number] => 16/063312 [patent_app_country] => US [patent_app_date] => 2016-12-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9503 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -71 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16063312 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15035661 [patent_doc_number] => 20190328835 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-10-31 [patent_title] => MEANS AND METHODS FOR TREATING COPPER-RELATED DISEASES [patent_app_type] => utility [patent_app_number] => 16/063220 [patent_app_country] => US [patent_app_date] => 2016-12-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17138 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -16 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16063220 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14611551 [patent_doc_number] => 10358461 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2019-07-23 [patent_title] => Precipitable peptides [patent_app_type] => utility [patent_app_number] => 15/377243 [patent_app_country] => US [patent_app_date] => 2016-12-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 26346 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15377243 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13604029 [patent_doc_number] => 20180353563 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-13 [patent_title] => NOVEL USE [patent_app_type] => utility [patent_app_number] => 16/060096 [patent_app_country] => US [patent_app_date] => 2016-12-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4088 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16060096 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13547143 [patent_doc_number] => 20180325119 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-15 [patent_title] => INSECTICIDAL PROTEINS AND METHODS FOR THEIR USE [patent_app_type] => utility [patent_app_number] => 15/774690 [patent_app_country] => US [patent_app_date] => 2016-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 86242 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -20 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15774690 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11662600 [patent_doc_number] => 20170151306 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-06-01 [patent_title] => 'DOSING REGIMENS FOR ECHINOCANDIN CLASS COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 15/371333 [patent_app_country] => US [patent_app_date] => 2016-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 26503 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15371333 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11515565 [patent_doc_number] => 20170082636 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2017-03-23 [patent_title] => 'METHOD OF DETECTING AT LEAST ONE MECHANISM OF RESISTANCE TO CARBAPENEMS BY MASS SPECTROMETRY' [patent_app_type] => utility [patent_app_number] => 15/370128 [patent_app_country] => US [patent_app_date] => 2016-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 61682 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15370128 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13574937 [patent_doc_number] => 20180339017 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-11-29 [patent_title] => CO-AGONISTS OF THE GLUCAGON AND GLP-1 RECEPTORS [patent_app_type] => utility [patent_app_number] => 15/774622 [patent_app_country] => US [patent_app_date] => 2016-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 19742 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -17 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15774622 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13603875 [patent_doc_number] => 20180353486 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2018-12-13 [patent_title] => METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DARIER DISEASE [patent_app_type] => utility [patent_app_number] => 15/780722 [patent_app_country] => US [patent_app_date] => 2016-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9215 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => 0 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15780722 [rel_patent_id] =>[rel_patent_doc_number] =>)